1. Home
  2. Live Updates
  3. Janssen stelara

Live Breaking News & Updates on Janssen stelara

Stay informed with the latest breaking news from Janssen stelara on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Janssen stelara and stay connected to the pulse of your community

Teva, Alvotech obtain FDA OK for Stelara biosimilar

Selarsdi (ustekinumab-aekn) injection for subcutaneous use is for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis.

United-states , Janssen-stelara , Thomas-rainey , Teva-pharmaceuticals , Drug-administration-for-selarsdi , Drug-administration ,

Biologics and Biosimilars Landscape: IP, Policy, and Market Developments | Fish & Richardson

In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price...

West-virginia , United-states , California , Johns-hopkins-university , Maryland , Robertm-califf , Eli-lilly-emgality , Genentech-actemra , Janssen-stelara , Samsung-bioepis-merck , Eli-lilly-rezvoglar , Chugai-seiyaku-kabushiki-kaisha

Pearce IP BioBlast w/e 22 March 2024

On 22 March 2024, the first case management hearing was held before Justice Nicholas in the Federal Court of Australia, Sydney, in proceedings…

Canada , Guangzhou , Guangdong , China , Australia , India , South-korea , Vacaville , California , United-states , United-kingdom , Reykjavik

Pearce IP BioBlast w/e 8 March 2024

On 9 March 2024, Samsung Bioepis presented two papers of study results for its immunology portfolio at the 2024 American Academy of Dermatology (AAD)…

Australia , United-states , France , India , United-kingdom , China , California , Virginia , Canada , Switzerland , San-diego , American

The Inflation Reduction Act's First Potential Impact On Biosimilars - Life Sciences, Biotechnology & Nanotechnology

On October 31, 2023, FDA approved Amgen's Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Janssen's Stelara (ustekinumab). Stelara has been selected by the Center...

Amgen-wezlana , Janssen-stelara , Medicare-medicaid-services , Amgen , Medicaid-services , Inflation-reduction , Because-wezlana , Mondaq , Intellectual-property , Iosimilars , Food , Rugs

The Inflation Reduction Act's First Potential Impact On Biosimilars

On October 31, 2023, FDA approved Amgen's Wezlana as a biosimilar to and interchangeable with Janssen's Stelara . Stelara has been selected by the Center for Medicare & Medicaid Services as one of...

Janssen-stelara , Amgen-wezlana , Amgen , Medicare-medicaid-services , Medicaid-services , Inflation-reduction-act , Because-wezlana , Markets ,

The Inflation Reduction Act's First Potential Impact on Biosimilars | Axinn, Veltrop & Harkrider LLP

On October 31, 2023, FDA approved Amgen’s Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Janssen’s Stelara (ustekinumab). Stelara has been selected by the Center...

Janssen-stelara , Amgen-wezlana , Amgen , Medicare-medicaid-services , Veltrop-harkrider , Medicaid-services , Inflation-reduction-act , Because-wezlana ,

Bio-Thera Solutions Announces Positive Results from Phase 3 Study of BAT2206, a Proposed Biosimilar Referencing Stelara®

/PRNewswire/ -- Bio-Thera Solutions, Ltd. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets,...

China , Guangzhou , Guangdong , United-states , Min-zheng , Heilongjiang , America , Shengfeng-li , Janssen-stelara , Wechat-bio-thera , Congratulations-to-bio-thera-solutions , Bio-thera-solutions

Bio-Thera Solutions Announces Positive Results From Phase 3 Study Of BAT2206, A Proposed Biosimilar Referencing Stelara®

Bio-Thera Solutions Announces Positive Results From Phase 3 Study Of BAT2206, A Proposed Biosimilar Referencing Stelara®
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

China , Guangzhou , Guangdong , Min-zheng , Heilongjiang , United-states , America , Shengfeng-li , Wechat-bio-thera , Janssen-stelara , Bio-thera-solutions-announces-positive , Prnewswire-bio-thera-solutions-ltd

US Gastroenterologist Projections Suggest Significant Shift in Ulcerative Colitis Landscape ...

Exton, Pennsylvania, Nov. 13, 2023 (GLOBE NEWSWIRE) -- In the past two months, the landscape of available treatments for ulcerative colitis (UC) has undergone a significant expansion, marked by the

Pennsylvania , United-states , Celltrion-zymfentra , Lilly-omvoh , Abbvie-rinvoq , Eli-lilly-omvoh , Janssen-stelara , Takeda-entyvio , Linkedin , Dynamix , Twitter , Spherix-network